Loading company financials…
NASDAQ NMS - GLOBAL MARKET · Technology · CIK 0001878848
$25.51
-8.37% · delayed ~15 min
Last price from Oct 22, 2026
$8.06B market value
From IREN Ltd's FY2026 10-K, filed Aug 27, 2026 · read the filing
IREN lends money and provides credit. It took in $707.0M last year, which makes it a smaller company. It spends more than it earns — losing about 99 cents on every dollar of sales.
The financial picture is led by growth, while profitability and debt remain weak.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Recent open-market selling by Guzowski Christopher, not under a pre-arranged plan.
$434.3K sold in the last 120 days · Read the filing
These are things the company filed or that a published model flagged — not predictions, and not a reason on their own to buy or sell anything.
Financial health
A mixed picture — some clear strengths and some weaknesses.
From IREN Ltd's FY2026 annual filing · share price scored separately
Largest year-over-year changes in FY2026
Revenue
$501.0M → $707.0M
Gross profit
$342.0M → $487.3M
Operating income
$17.3M → -$1.05B
Profit
$86.9M → -$702.6M
Measured against FY2025, from the 10-K filed Aug 27, 2026
Improved: +41.1%
$501.0M to $707.0MCritical
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
How the latest move compares (quote delayed ~15 min), and what was published around it
IREN fell 8.37% on the latest quote. The average Financials company tracked here moved +1.11%, and the S&P 500 −1.04%. That is 9.5 points below its sector and 7.3 points below the market.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
Opinions from 25 analysts covering this company, as of . Their views, not this site's.
Of 25 analysts publishing on this company, 7 say strong buy, 14 say buy and 4 say hold. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
The essentials
Each answered from the filings, with the numbers behind it.
No. It lost $702.6M last year, losing about 99 cents on every dollar of sales.
Yes, quickly. Sales grew 41.1% last year.
For every $1 it owes, it owns $1.36 in assets. Banks and insurers always carry high debt — that is how lending works — so this is normal for the industry and not comparable with other sectors. Its operating profit does not cover its interest bill — -22.47x against the interest it owes.
Core operating and valuation reference metrics
Income
This company pays no dividend. It keeps its profits and reinvests them in the business instead, so any return would have to come from the share price.
Figures from the FY2026 annual filing
Last year it lost $702.6M and generated $2.10B of cash from operations.
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202610-K · Aug 27, 2026Filing for FY2026 | FY202510-K · Aug 27, 2026Filing for FY2025 | FY202410-K · Aug 28, 2025Filing for FY2024 | FY202320-F/A · Aug 28, 2025Filing for FY2023 | FY202220-F · Aug 28, 2025Filing for FY2022 | ChangeFY2026 vs FY2025 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $707.0M | $501.0M | $187.2M | $75.5M | $59.0M | +41.1% |
| Cost of revenue | $219.7M | $159.0M | $87.1M | $39.4M | — | +38.2% |
| Gross profit | $487.3M† | $342.0M† | $100.1M† | $36.1M† | — | +42.5% |
| Gross marginGross profit ÷ revenueWhat is this? | 68.9% | 68.3% | 53.5% | 47.8% | — | +0.7 pts |
| Selling, general and administrative | $449.1M | $136.5M | $70.4M | $49.0M | — | +229.1% |
| Operating income | -$1.05B | $17.3M | -$27.2M | -$157.2M | $307.0K | n/m |
| Operating marginOperating income ÷ revenueWhat is this? | -148.0% | 3.5% | -14.5% | -208.2% | 0.5% | −151.5 pts |
| Interest expense | $46.6M | $10.5M | $0.00 | $15.2M | $5.3M | +345.6% |
| Income before tax | -$708.7M | $93.5M | -$25.5M | -$169.4M | -$417.0M | n/m |
| Net income | -$702.6M | $86.9M | -$28.9M | -$171.8M | -$419.8M | n/m |
| Net marginNet income ÷ revenueWhat is this? | -99.4% | 17.4% | -15.4% | -227.6% | -711.0% | −116.7 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $-2.22 | $0.4052 | $-0.2902 | $-3.14 | — | n/m |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| IRENIREN Ltd · this page | 4.7/10 | 3/9 | 41.1% | -99.4% | — | 2.77x |
| TEAM |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Was granted or awarded shares — 8,369 shares
Holds 153,574 shares after this filing.
Was granted or awarded shares — 6,657 shares
Holds 127,606 shares after this filing.
Was granted or awarded shares
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Proxy statement for a shareholder meeting
Read the filingAnnual report for FY2026
Revenue +41.1% · Operating margin −151.5 pts · Gross profit +42.5% — against FY2025
Read the filingWrite down why you are following IREN Ltd, what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
The 7 subsidiaries named in its 10-K. A filer lists the significant ones and may leave the rest out, so this is the floor rather than the full count.
Source: of the 10-K filed 2026-08-27. These are legal entities, not brands or acquisitions — a company that bought a business may hold it inside an entity named here, or inside one small enough that the rule does not require naming it at all.
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from IREN's 10-K for fiscal year 2026 (period ending 2026-06-30, filed Aug 27, 2026), reported under the US GAAP taxonomy. View the source filing.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 9 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2026 | 4.7 | 3/9 | 10-K, filed Aug 27, 2026 |
| FY2025 | 7.3 | 6/8 | 10-K, filed Aug 28, 2025 |
| FY2024 | 6.0 | 5/8 | 10-K, filed Aug 28, 2025 |
| FY2023 | 4.7 | 6/7 | 20-F, filed Sep 13, 2023 |
| FY2022 | 4.7 | 5/7 | 20-F, filed Sep 13, 2022 |
| FY2021 | 4.7 | 2/7 | 20-F, filed Sep 13, 2022 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
3 of 9 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2026 filing as filed with the SEC.
Improved: +42.5%
$342.0M to $487.3MCritical
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Deteriorated: turned negative
$17.3M to -$1.05BCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Deteriorated: turned negative
$86.9M to -$702.6MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: −151.5 pts
3.5% to -148.0%Critical
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Deteriorated: −116.7 pts
17.4% to -99.4%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: $570.0M wider
-$327.6M to -$897.6MCritical
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
Deteriorated: turned negative
$0.41 to -$2.22Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: +671.1%
$962.8M to $7.42BCritical
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Improved: +944.3%
$564.5M to $5.90BCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Deteriorated: +47.3%
214.6M to 316.1MCritical
Why it matters: New shares divide the same company into more pieces, so each existing holding owns slightly less of it. Often pay for staff or an acquisition rather than anything wrong.
Changed: +422.8%
$573.5M to $3.00BCritical
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
1 other measure barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 25.8% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
Trailing P/E is not meaningful because the latest trailing earnings are zero or negative. The price-to-book and price-to-sales figures below still provide reference points.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Reported annual figures
| 6.0/10 |
| 7/9 |
| 26.0% |
| -0.8% |
| — |
| 4.77x |
| Median of peers | 6.0/10 | — | 26.0% | -0.8% | — | 4.77x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Holds 23,089,024 shares after this filing.
Was granted or awarded shares — 552,197 shares
Holds 23,641,221 shares after this filing.
Was granted or awarded shares — 9,099,328 shares
Holds 23,089,024 shares after this filing.
Was granted or awarded shares — 552,197 shares
Holds 23,641,221 shares after this filing.
Was granted or awarded shares — 6,657 shares
Holds 76,691 shares after this filing.
Sold on the open market — 11,958 shares at $36.32 ($434.3K)
Holds 39,168 shares after this filing.
Was granted or awarded shares — 6,657 shares
Holds 45,825 shares after this filing.
Was granted or awarded shares — 26,968 shares
Holds 221,483 shares after this filing.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Published results
Made a Regulation FD disclosure
Read the filingMade a Regulation FD disclosure · Reported another event
Read the filingPublished results
Read the filingHad a director or senior officer leave or join
Read the filingSigned a material agreement · Took on a direct financial obligation
Read the filingSigned a material agreement · Made a Regulation FD disclosure
Read the filingSigned a material agreement · Took on a direct financial obligation · Sold shares outside a public offering · Reported another event
Read the filingReported another event
Read the filingReported another event
Read the filingPublished results
Read the filingQuarterly report for Q3 FY2026
Operating margin −181.4 pts · Operating income turned negative · Profit $231.7M wider — against Q3 FY2026
Read the filingPublished results
Read the filingReported another event
Read the filingSigned a material agreement · Made a Regulation FD disclosure
Read the filingQuarterly report for Q2 FY2026
Revenue +59.0% · Operating margin −77.9 pts · Gross profit +41.8% — against Q2 FY2026
Read the filingPublished results
Read the filingSigned a material agreement · Took on a direct financial obligation · Sold shares outside a public offering · Reported another event
Read the filingCoverage from the last 30 days
IREN Stock Fell 8% in a Day After Its Spain Campus Rally. Here’s What Wall Street’s Targets Imply
Yahoo Finance ·
The Neocloud Bloodbath: NBIS, IREN, and CRWV Selloff Continues
Yahoo Finance ·
IREN vs. TeraWulf: Which AI Infrastructure Stock Carries Less Risk Now?
Yahoo Finance ·
IREN (IREN) Lands 300 MW Spain License And Opens IREN Europe
Yahoo Finance ·
IREN’s 300 MW data center in Spain would be on of Europe’s largest
Yahoo Finance ·
IREN secures license for 300 MW data center in Spain
Yahoo Finance ·
Data Center Stocks Rise as IREN Plans 300MW AI Campus in Spain: IREN and Cipher Digital Gain 4%, Core Scientific Climbs 3%
Yahoo Finance ·
IREN Stock Rises: AI Cloud Provider Plans 300MW AI Campus In Spain For 2028
Yahoo Finance ·
SpaceX Q3 Earnings, Soluna’s 50 MW Applied Digital JV, IREN’s 300 MW Spain Site
Yahoo Finance ·
TeraWulf Jumps 8% as CEO Says Power Demand Remains ‘Extremely Strong’; Applied Digital Surges 9%, IREN Climbs 6%
Yahoo Finance ·
Nebius Stock Fell 7% the Day It Announced a $3.5 Billion Citi Facility. Here’s What Its CEO Said About How Long the AI Chip Shortage Lasts
Yahoo Finance ·
Stock Market Today, Oct. 22: CoreWeave Slides on Bernstein Downgrade and Financing Worries
Yahoo Finance ·
Primary sources and further research